Tchaikapharma High Quality Medicines AD (BUL:THQM)

Market Cap	1.51B
Revenue (ttm)	55.97M
Net Income (ttm)	5.19M
Shares Out	91.80M
EPS (ttm)	0.05
PE Ratio	291.79
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	400
Average Volume	502
Open	16.50
Previous Close	17.60
Day's Range	16.50 - 16.50
52-Week Range	8.10 - 18.00
Beta	0.05
RSI	58.68
Earnings Date	Apr 25, 2025

About BUL:THQM

Tchaikapharma High Quality Medicines AD engages in the development and manufacture of generic and in-licensed medicines in Bulgaria. The company offers anaesthetic, anti-inflammatory and anti-rheumatic, antibiotic, cardiovascular system, digestive system, diabetes and metabolism, nervous system, OTC, respiratory system, oncology, and other medicines. It also provides nutritional supplements. The company was founded in 1999 and is headquartered in Sofia, Bulgaria.

• Industry: Pharmaceutical Preparations
• Founded: 1999
• Employees: 108
• Stock Exchange: Bulgarian Stock Exchange
• Ticker Symbol: THQM

Financial Performance

In 2024, BUL:THQM's revenue was 53.14 million, an increase of 9.54% compared to the previous year's 48.51 million. Earnings were 4.49 million, an increase of 32.12%.